Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LAIS
- Development stage
- Unknown
- Lead developer
- Lofarma
- Modality
- Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Sublingual
01
Overview
LAIS refers to a line of sublingual allergoid tablets used for allergen immunotherapy. These preparations are designed to treat allergic conditions such as allergic rhinitis and rhinoconjunctivitis, particularly those induced by tree pollen or house dust mites. The treatment aims to alleviate symptoms by administering modified allergens (allergoids) sublingually, thereby inducing immune tolerance. Clinical studies have focused on expanding knowledge regarding the application, tolerability, and symptom alleviation of LAIS allergoid tablets in everyday practice, including specific titration schedules and in larger patient populations.
- Brand names
- LAIS® 2-tree allergoid tabletsLAIS® Mites Sublingual tabletsLAIS® Mites allergoid tablets
02
Targets
IgE (Immunoglobulin E)
Beyond the preview
Go deeper on LAIS.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LAIS.